Peli BioThermal, the global partner to the life sciences industry and a leader in temperature-controlled packaging and services, and PAXAFE, a pioneering pharmaceutical logistics & quality intelligence platform, announced a strategic partnership that brings together proven cold chain packaging expertise and cutting-edge digital innovation united by a single purpose: to protect the integrity of pharmaceutical supply chains worldwide.
Packaging Excellence Meets Digital Intelligence – A Comprehensive Approach to Critical Pharma Supply Chains
Peli BioThermal is the trusted cold chain partner to the global life sciences industry, providing temperature-controlled packaging and services that protect pharmaceuticals, biologics, vaccines, and advanced therapies during transport. The company has earned a reputation for reliability, innovation, and performance across even the most demanding pharmaceutical supply chains. Through a portfolio that includes the Crēdo Vault bulk shipper, CrēdoGO reusable shipper, and DV10 dry vapor shipper, Peli BioThermal continues to invest in solutions that help customers protect critical products and operate with confidence as regulatory requirements evolve and supply chains become increasingly complex.
PAXAFE brings a purpose-built pharmaceutical logistics intelligence platform to the partnership, designed specifically for the regulatory and operational demands of GDP- and GMP-governed environments. With a focus on lane planning, real-time visibility, quality operations and predictive analytics, PAXAFE delivers the digital depth that modern pharmaceutical supply chains require – turning complex logistics data into actionable intelligence that reduces risk, ensures compliance, and protects patient outcomes.
Also Read: Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Together, Peli BioThermal and PAXAFE address the full spectrum of pharmaceutical supply chain needs: from the physical protection and transport of sensitive products in the field to the intelligent analysis, alerting, and compliance reporting that regulated industries depend on. Together, both companies are strengthening their offering with advanced compliance capabilities for GDP/GMP-regulated environments.
Sam Herbert, CEO, Peli BioThermal: “Peli BioThermal has built its reputation by being the partner life sciences companies can rely on when it matters most – protecting products at every stage of the cold chain. Partnering with PAXAFE is the logical next step in that journey. Together, we give the pharmaceutical industry something it has always needed: proven cold chain packaging reliability combined with the power of cutting-edge digital intelligence in a single, fully integrated solution.”
Doug Ross, President and COO, Peli BioThermal: “Innovation has always been at the heart of how Peli BioThermal serves the life sciences industry. We continually challenge ourselves to look beyond traditional cold chain solutions and develop new ways to create value for our customers. Our partnership with PAXAFE brings together trusted packaging expertise and advanced digital intelligence to deliver a smarter, more connected future for pharmaceutical logistics. This is more than a technology integration-it’s an example of how innovation can solve real-world challenges at scale.”
Ilya Preston, CEO, PAXAFE: “Trust in the pharmaceutical supply chain is not given – it is earned, over time, through consistent performance and an unwavering focus on outcomes. What we are building together is not a vendor relationship – it is a shared commitment to raising the standard of what integrated pharmaceutical supply chain monitoring can deliver. That commitment is what the industry has been waiting for.”
Brian Shultz, Chief Growth Officer, PAXAFE: “The market opportunity here is significant – and it is grounded in a real, unmet need. Pharmaceutical companies are under growing pressure to demonstrate compliance, reduce losses, deliver end-to-end transparency across their supply chains. What Peli BioThermal and PAXAFE bring to market together is an integrated answer to that challenge – combining proven cold chain packaging reliability with the predictive intelligence modern pharma logistics demands. Together, we are not just responding to market demand – we are defining what comes next.”
SOURCE: PRNewswire